Effective testosterone treatment reduces incidence of atrial fibrillation
- Ineffective testosterone treatment, which does not achieve large enough elevations in testosterone levels, does not confer benefits.
What is known about testosterone and atrial fibrillation?
What this study adds
Table 1: Reduction in risk of atrial fibrillation in men receiving effective vs. ineffective testosterone treatment, compared to non-treated hypogonadal men.
Data from Sharma, R., et al., Normalization of Testosterone Levels After Testosterone Therapy Is Associated With Decreased Incidence of Atrial Fibrillation. J Am Heart Assoc, 2017. 6(5)
Importance of adherence and achievement of effective (therapeutic) testosterone levels
Protective mechanisms of testosterone
A report of two case studies suggested that testosterone could be used as an atrial fibrillation treatment in aging men 22, which is supported by the study presented here.
- Sharma, R., et al., Normalization of Testosterone Levels After Testosterone Therapy Is Associated With Decreased Incidence of Atrial Fibrillation. J Am Heart Assoc, 2017. 6(5). Return to content
- Lip, G.Y.H., C.M. Brechin, and D.A. Lane, The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest, 2012. 142(6): p. 1489-1498. Return to content
- Go, A.S., et al., Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001. 285(18): p. 2370-5. Return to content
- Benjamin, E.J., et al., Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 2017. 135(10): p. e146-e603. Return to content
- Heeringa, J., et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J, 2006. 27(8): p. 949-53. Return to content
- Lai, J., et al., Reduced testosterone levels in males with lone atrial fibrillation. Clin Cardiol, 2009. 32(1): p. 43-6. Return to content
- Liu, T., et al., Androgens and atrial fibrillation: friends or foes? Int J Cardiol, 2010. 145(2): p. 365-7. Return to content
- Tsuneda, T., et al., Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model. J Cardiovasc Electrophysiol, 2009. 20(9): p. 1055-60. Return to content
- Magnani, J.W., et al., Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol, 2014. 7(2): p. 307-12. Return to content
- Sullivan, M.L., C.M. Martinez, and E.J. Gallagher, Atrial fibrillation and anabolic steroids. J Emerg Med, 1999. 17(5): p. 851-7. Return to content
- Lau, D.H., et al., Atrial fibrillation and anabolic steroid abuse. Int J Cardiol, 2007. 117(2): p. e86-7. Return to content
- Akcakoyun, M., et al., Long-term anabolic androgenic steroid use is associated with increased atrial electromechanical delay in male bodybuilders. Biomed Res Int, 2014. 2014: p. 451520. Return to content
- Sharma, R., et al., Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J, 2015. 36(40): p. 2706-15. Return to content
- Sharma, R., et al., Association Between Testosterone Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database. Chest, 2016. 150(3): p. 563-71. Return to content
- Cheetham, T.C., et al., Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency. JAMA Intern Med, 2017. 177(4): p. 491-499. Return to content
- Kourliouros, A., et al., Current concepts in the pathogenesis of atrial fibrillation. Am Heart J, 2009. 157(2): p. 243-52. Return to content
- Joseph, P., et al., Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation. Int J Cardiovasc Imaging, 2016. 32(1): p. 113-9. Return to content
- Henningsen, K.M., et al., Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Scand J Clin Lab Invest, 2009. 69(3): p. 425-32. Return to content
- Bobjer, J., et al., Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS One, 2013. 8(4): p. e61466. Return to content
- Kupelian, V., et al., Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf), 2010. 72(4): p. 527-33. Return to content
- Malkin, C.J., et al., The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab, 2004. 89(7): p. 3313-8. Return to content
- Eby, G., Testosterone as an atrial fibrillation treatment and stroke preventative in aging men: case histories and hypothesis. Med Hypotheses, 2010. 75(2): p. 269-70. Return to content